Cupid promoter Aditya Halwasiya buys 13.96 lakh shares in open market

Cupid Limited reported a significant open market acquisition by its promoter and Chairman and Managing Director, Aditya Kumar Halwasiya. On August 17, 2026, Halwasiya purchased 1,395,538 equity shares of face value Re 1 each, marking a direct increase in his ownership stake in the condom and diagnostics manufacturer.

The acquisition was made in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure highlights a consolidation of promoter interest, with no corresponding disposals or encumbrances recorded during the period.

Shareholding Pattern Changes

The open market purchase adjusted the individual and group holding structures within Cupid Limited. While Halwasiya’s stake increased by 0.10%, the holding of other promoter entities remained unchanged.

Shareholder	Shares Held Before	% Holding Before	Shares Acquired	Shares Held After	% Holding After
Aditya Kumar Halwasiya	447,625,475	33.29%	1,395,538	449,021,013	33.39%
Columbia Petro Chem Pvt Ltd	174,199,250	12.95%	0	174,199,250	12.95%
Promoter Group Total	621,824,725	46.24%	1,395,538	623,220,263	46.34%

The total diluted share/voting capital of the company stands at 13,47,00,000 equity shares. The acquisition does not involve any warrants, convertible securities, or voting rights other than those attached to equity shares.

Regulatory Compliance

Cupid Limited filed the disclosure with both the Bombay Stock Exchange and the National Stock Exchange of India on August 17, 2026. Hardik Meghji Chandra, Company Secretary and Compliance Officer, certified the receipt of the disclosure from the promoter. The filing confirms that no shares were encumbered or pledged as part of this transaction.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-9.04%	+1.98%	+23.32%	+229.01%	+696.07%	+11,227.12%

Cupid Limited corrected an inadvertent typographical error in its disclosure of unaudited financial results for the quarter ended June 30, 2026, clarifying that the accompanying documents were limited review reports rather than audited financial statements. The correction, issued on August 11, 2026, ensures regulatory accuracy but confirms that no financial figures or operational data have been altered from the original announcement made on August 07, 2026.

The company initially described the documents as "Auditor’s Report on both the Quarterly Audited Standalone and Consolidated Financial Results." The corrected disclosure accurately labels them as "Limited Review Reports on both the Quarterly Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026." This distinction is critical for investors to understand the level of assurance provided by the statutory auditors, Chaturvedi Sohan & Co., Chartered Accountants (FRN: 118424W).

Financial Results Remain Unchanged

Despite the terminological correction, the standalone net profit for Q1FY27 remains at ₹44.16 crore, representing a 194% year-on-year increase from ₹15.02 crore in Q1FY26. Revenue from operations stood at ₹15,471.50 lakh (₹154.72 crore), up 159% from ₹5,980.49 lakh in the corresponding period last year. The Board of Directors had approved these results pursuant to Regulation 30 and Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Particulars:	Q1FY27 (₹ Lacs)	Q1FY26 (₹ Lacs)	Change (%)
Revenue from Operations	15,471.50	5,980.49	159%
Total Income	15,698.01	6,474.68	142%
Total Expenses	9,704.80	4,518.51	115%
Net Profit After Tax	4,416.21	1,501.77	194%
Basic EPS (₹)	0.33	0.11	200%

Consolidated net profit was reported at ₹44.15 crore, compared to ₹15.01 crore in Q1FY26. The total comprehensive income was ₹1.71 crore, impacted by a ₹42.46 crore loss on equity instruments measured at fair value through Other Comprehensive Income (OCI). This valuation adjustment relates to the company's strategic investment in Baazar Style Retail Limited, involving fully convertible warrants held for conversion into equity shares within 18 months.

Strategic Initiatives and Governance

The Board also granted in-principle approval for an exploratory exercise to evaluate a proposed business project in West Bengal, aimed at assessing land availability and infrastructure for manufacturing medical devices and healthcare products. Additionally, the Board considered the continuation of Mr. Thallapaka Venkateswara Rao as a Non-Executive Independent Director post-attaining the age of 75 years, subject to shareholder approval via special resolution at the ensuing Annual General Meeting.